Premium
Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab
Author(s) -
Chodziuk Astrid C.,
Ghazanfar Misbah N.,
Thomsen Simon F.
Publication year - 2019
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12902
Subject(s) - medicine , omalizumab , university hospital , dermatology , family medicine , immunoglobulin e , antibody , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom